Immuneed AB is a Swedish AB based in Uppsala, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2014, the company reported revenue of SEK 11.3m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna eller en av dem i förening med Kele, Alexander Josef Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning och utveckling samt service- verksamhet inom biomedicin, medicin, immunologi och cancer och därmed förenlig verksamhet.
In its most recent annual report (2025), Immuneed AB reported revenue of SEK 11.3m, a decrease of 7% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 7.2m, and the EBITDA margin stood at -60.5%.
At the end of 2025, equity financed 45.6% of the balance sheet, and current assets covered short-term debt 1.7 times.
Frequently asked questions
What is the Org number of Immuneed AB?
Immuneed AB is registered with Bolagsverket / SCB under Org 5569744807.
What is the revenue of Immuneed AB?
Immuneed AB reported revenue of SEK 11.3m in 2025.
Who is the CEO of Immuneed AB?
Alexander Josef Kele is the CEO of Immuneed AB, in role since 2025.
Who is the chairman of Immuneed AB?
Philippe Paul G Stas chairs the board of Immuneed AB, in role since 2025.
Where is Immuneed AB headquartered?
Immuneed AB's registered address is Kungsgatan 70 D.
